Eli Lilly allows physicians to seek retatrutide access
Eli Lilly has built a formal expanded access program for retatrutide, its experimental obesity drug, following weeks of physician inquiries about securing the same early access previously granted to a single patient. “For a limited number of patients who meet specific medical criteria and cannot enroll in a clinical trial, we believe it is medically […] The post Eli Lilly allows physicians to seek retatrutide access appeared first on Becker's Hospital Review | Healthcare News &a...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.